Characterization of chromosomal instability in murine colitis-associated colorectal cancer

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Gerling, Marco ^a   Glauben, Rainer ^a   Habermann, Jens K ^b   Kühl, Anja A ^a   Loddenkemper, Christoph ^a   Lehr, Hans Anton ^c   Zeitz, Martin ^a   Siegmund, Britta ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; GAMMA INTERFERON; KI 67 ANTIGEN; PROTEIN P53; AZOXYMETHANE; DEXTRAN SULFATE; INTERLEUKIN 10;

ANEUPLOIDY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RISK; CANCER STAGING; CHROMOSOMAL INSTABILITY; CHROMOSOME TRANSLOCATION; CHRONIC INFLAMMATION; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; IMAGE CYTOMETRY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR GROWTH; ULCERATIVE COLITIS; ANIMAL; CELL PROLIFERATION; COLITIS; COLORECTAL TUMOR; DIGESTIVE TRACT ENDOSCOPY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY;

MURINAE; MUS;

ANIMALS; AZOXYMETHANE; BETA CATENIN; CELL PROLIFERATION; CHROMOSOMAL INSTABILITY; COLITIS; COLORECTAL NEOPLASMS; DEXTRAN SULFATE; ENDOSCOPY, DIGESTIVE SYSTEM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; KI-67 ANTIGEN; MICE; NEOPLASM STAGING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79960672111     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022114     Document Type: Article

References (43)

1. Bernstein CN, Blanchard JF, Kliewer E, Wajda A, (2001) Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 91: 854-862.
2. Pohl C, Hombach A, Kruis W, (2000) Chronic inflammatory bowel disease and cancer. Hepatogastroenterology 47: 57-70.
3. Kanai Y, (2010) Genome-wide DNA methylation profiles in precancerous conditions and cancers. Cancer Sci 101: 36-45.
4. Yan B, Peng Y, Li CY, (2009) Molecular analysis of genetic instability caused by chronic inflammation. Methods Mol Biol 512: 15-28.
5. Risques RA, Lai LA, Brentnall TA, Li L, Feng Z, et al. (2008) Ulcerative colitis is a disease of accelerated colon aging: evidence from telomere attrition and DNA damage. Gastroenterology 135: 410-418.
6. Paulson TG, Maley CC, Li X, Li H, Sanchez CA, et al. (2009) Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma. Clin Cancer Res 15: 3305-3314.
7. Goldberg-Bittman L, Kitay-Cohen Y, Hadari R, Yukla M, Fejgin MD, et al. (2008) Random aneuploidy in chronic hepatitis C patients. Cancer Genet Cytogenet 180: 20-23.
8. Habermann J, Lenander C, Roblick UJ, Kruger S, Ludwig D, et al. (2001) Ulcerative colitis and colorectal carcinoma: DNA-profile, laminin-5 gamma2 chain and cyclin A expression as early markers for risk assessment. Scand J Gastroenterol 36: 751-758.
9. Befrits R, Hammarberg C, Rubio C, Jaramillo E, Tribukait B, (1994) DNA aneuploidy and histologic dysplasia in long-standing ulcerative colitis. A 10-year follow-up study. Dis Colon Rectum 37: 313-319; discussion 319-320.
10. Gerling M, Meyer KF, Fuchs K, Igl BW, Fritzsche B, et al. (2010) High Frequency of Aneuploidy Defines Ulcerative Colitis-Associated Carcinomas: A Comparative Prognostic Study to Sporadic Colorectal Carcinomas. Ann Surg 252 (1): 84-89.
11. Araujo SE, Bernardo WM, Habr-Gama A, Kiss DR, Cecconello I, (2007) DNA ploidy status and prognosis in colorectal cancer: a meta-analysis of published data. Dis Colon Rectum 50: 1800-1810.
12. Yin J, Harpaz N, Tong Y, Huang Y, Laurin J, et al. (1993) p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. Gastroenterology 104: 1633-1639.
13. Brentnall TA, Crispin DA, Rabinovitch PS, Haggitt RC, Rubin CE, et al. (1994) Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 107: 369-378.
14. Chaubert P, Benhattar J, Saraga E, Costa J, (1994) K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis. Am J Pathol 144: 767-775.
15. Harpaz N, Peck AL, Yin J, Fiel I, Hontanosas M, et al. (1994) p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma. Hum Pathol 25: 1069-1074.
16. Su LK, Vogelstein B, Kinzler KW, (1993) Association of the APC tumor suppressor protein with catenins. Science 262: 1734-1737.
17. Tomlinson I, Ilyas M, Johnson V, Davies A, Clark G, et al. (1998) A comparison of the genetic pathways involved in the pathogenesis of three types of colorectal cancer. J Pathol 184: 148-152.
18. Claessen MM, Schipper ME, Oldenburg B, Siersema PD, Offerhaus GJ, et al. WNT-pathway activation in IBD-associated colorectal carcinogenesis: potential biomarkers for colonic surveillance. Cell Oncol 32: 303-310.
19. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, et al. (1990) A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98: 694-702.
20. Ishioka T, Kuwabara N, Oohashi Y, Wakabayashi K, (1987) Induction of colorectal tumors in rats by sulfated polysaccharides. Crit Rev Toxicol 17: 215-244.
21. Yamada M, Ohkusa T, Okayasu I, (1992) Occurrence of dysplasia and adenocarcinoma after experimental chronic ulcerative colitis in hamsters induced by dextran sulphate sodium. Gut 33: 1521-1527.
22. Tanaka T, Kohno H, Suzuki R, Yamada Y, Sugie S, et al. (2003) A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci 94: 965-973.
23. Guda K, Upender MB, Belinsky G, Flynn C, Nakanishi M, et al. (2004) Carcinogen-induced colon tumors in mice are chromosomally stable and are characterized by low-level microsatellite instability. Oncogene 23: 3813-3821.
24. Suzuki R, Kohno H, Sugie S, Tanaka T, (2005) Dose-dependent promoting effect of dextran sodium sulfate on mouse colon carcinogenesis initiated with azoxymethane. Histol Histopathol 20: 483-492.
25. Hegazi RA, Mady HH, Melhem MF, Sepulveda AR, Mohi M, et al. (2003) Celecoxib and rofecoxib potentiate chronic colitis and premalignant changes in interleukin 10 knockout mice. Inflamm Bowel Dis 9: 230-236.
26. Berg DJ, Davidson N, Kuhn R, Muller W, Menon S, et al. (1996) Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest 98: 1010-1020.
27. Glauben R, Sonnenberg E, Zeitz M, Siegmund B, (2009) HDAC inhibitors in models of inflammation-related tumorigenesis. Cancer Lett 280: 154-159.
28. Becker C, Fantini MC, Wirtz S, Nikolaev A, Kiesslich R, et al. (2005) In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy. Gut 54: 950-954.
29. Auer GU, Caspersson TO, Gustafsson SA, Humla SA, Ljung BM, et al. (1980) Relationship between nuclear DNA distribution and estrogen receptors in human mammary carcinomas. Anal Quant Cytol 2: 280-284.
30. Siegmund B, Lehr HA, Fantuzzi G, (2002) Leptin: a pivotal mediator of intestinal inflammation in mice. Gastroenterology 122: 2011-2025.
31. Beatty PL, Plevy SE, Sepulveda AR, Finn OJ, (2007) Cutting edge: transgenic expression of human MUC1 in IL-10-/- mice accelerates inflammatory bowel disease and progression to colon cancer. J Immunol 179: 735-739.
32. Chichlowski M, Sharp JM, Vanderford DA, Myles MH, Hale LP, (2008) Helicobacter typhlonius and Helicobacter rodentium differentially affect the severity of colon inflammation and inflammation-associated neoplasia in IL10-deficient mice. Comp Med 58: 534-541.
33. Castro-Santos P, Suarez A, Lopez-Rivas L, Mozo L, Gutierrez C, (2006) TNFalpha and IL-10 gene polymorphisms in inflammatory bowel disease. Association of-1082 AA low producer IL-10 genotype with steroid dependency. Am J Gastroenterol 101: 1039-1047.
34. Franke A, Balschun T, Karlsen TH, Sventoraityte J, Nikolaus S, et al. (2008) Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 40: 1319-1323.
35. Clapper ML, Cooper HS, Chang WC, (2007) Dextran sulfate sodium-induced colitis-associated neoplasia: a promising model for the development of chemopreventive interventions. Acta Pharmacol Sin 28: 1450-1459.
36. Clevers H, (2006) Wnt/beta-catenin signaling in development and disease. Cell 127: 469-480.
37. Rosenberg DW, Giardina C, Tanaka T, (2009) Mouse models for the study of colon carcinogenesis. Carcinogenesis 30: 183-196.
38. Benson AB 3rd, (2007) Epidemiology, disease progression, and economic burden of colorectal cancer. J Manag Care Pharm 13: S5-18.
39. O'Sullivan JN, Bronner MP, Brentnall TA, Finley JC, Shen WT, et al. (2002) Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat Genet 32: 280-284.
40. Wright WE, Shay JW, (2000) Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology. Nat Med 6: 849-851.
41. Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, et al. (2000) Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406: 641-645.
42. Kurze A, Michie KA, Dixon SE, Mishra A, Itoh T, et al. (2010) A positively charged channel within the Smc1/Smc3 hinge required for sister chromatid cohesion. Embo J 30: 364-378.
43. Barber TD, McManus K, Yuen KW, Reis M, Parmigiani G, et al. (2008) Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers. Proc Natl Acad Sci U S A 105: 3443-3448.